Insider Sellers Might Regret Selling Olema Pharmaceuticals Shares at a Lower Price Than Current Market Value
Olema Pharmaceuticals, Inc.'s (NASDAQ:OLMA) stock price has dropped 11% in the previous week, but insiders who sold US$1.6m in stock over the past year have had less luck. Insiders might have been be
Olema Pharmaceuticals(OLMA.US) Director Sells US$215.4K in Common Stock
$Olema Pharmaceuticals(OLMA.US)$ Director Harmon Cyrus sold 20,000 shares of common stock on Jun 28, 2024 at an average price of $10.77 for a total value of $215.4K.Source: Announcement What is statem
Express News | Olema Pharmaceuticals: Amendment Increases Aggregate Principal Amount of Loan Facility to up to $100 Mln
Express News | Olema Pharmaceuticals: Got Into First Amendment to Loan & Security Agreement
Form 144 | Olema Pharmaceuticals(OLMA.US) Director Proposes to Sell 215.35K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $Olema Pharmaceuticals(OLMA.US)$ Director Harmon Cyrus intends to sell 20,000 shares of its common stock on Jun 28, with a total market value of approximately $215.35K.
Olema Pharmaceuticals(OLMA.US) Director Sells US$17.45 Million in Common Stock
$Olema Pharmaceuticals(OLMA.US)$ Director Graham G. Walmsley sold 1.18 million shares of common stock on Jun 4, 2024 at an average price of $14.85 for a total value of $17.45 million.Source: Announcem
Form 144 | Olema Pharmaceuticals(OLMA.US) Director Proposes to Sell 6.65 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 6, $Olema Pharmaceuticals(OLMA.US)$ Director Logos Opportunities Fund II LP intends to sell 475K shares of its common stock on Jun 4, with a total market value of approxima
Form 144 | Olema Pharmaceuticals(OLMA.US) Director Proposes to Sell 9.79 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 6, $Olema Pharmaceuticals(OLMA.US)$ Director Logos Opportunities Fund I LP intends to sell 700K shares of its common stock on Jun 4, with a total market value of approximat
Olema Pharmaceuticals(OLMA.US) Director Sells US$257.45K in Common Stock
$Olema Pharmaceuticals(OLMA.US)$ Director Harmon Cyrus sold 25,000 shares of common stock on May 31, Jun 3, 4, 2024 at an average price of $10.3 for a total value of $257.45K.Source: Announcement What
Capital One Financial Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $26
Capital One Financial analyst Naureen Quibria maintains $Olema Pharmaceuticals(OLMA.US)$ with a buy rating, and maintains the target price at $26.According to TipRanks data, the analyst has a success
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and
Dow, S&P, and Nasdaq Finished Higher After a Choppy Trading Session
Pfizer Data for Breast Cancer Therapy Sends Olema Higher
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersConcord Medical Services (NYSE:CCM) shares moved upwards by 51.9% to $1.2 during Tuesday's regular session. The market value of their outstanding shares is at $52.1 million. Annexon (NASDAQ:ANN
Olema Pharmaceuticals Up Over 23%, on Pace for Record Percent Increase -- Data Talk
Olema Pharmaceuticals, Inc. (OLMA) is currently at $11.94, up $2.26 or 23.35% --Would be highest close since March 13, 2024, when it closed at $12.50 --Would be largest percent increase on record (B
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Science Applications International Corporation (NASDAQ:SAIC) declined 11% to $119.91 following first-quarter results.SAIC reported a 9% revenue decline year over year in the fiscal first qua
12 Health Care Stocks Moving In Monday's Intraday Session
GainersStructure Therapeutics (NASDAQ:GPCR) stock moved upwards by 71.0% to $58.47 during Monday's regular session. The market value of their outstanding shares is at $2.7 billion. Concord Medical Ser
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Monday.Shares of Stericycle, Inc. (NASDAQ:SRCL) rose sharply during Monday's session after the company inked a deal to be
Form 144 | Olema Pharmaceuticals(OLMA.US) Director Proposes to Sell 141.13K in Common Stocks
SEC FILLINGS DISCLOSED/ May 31, $Olema Pharmaceuticals(OLMA.US)$ Director Harmon Cyrus intends to sell 15,000 shares of its common stock on May 31, with a total market value of approximately $141.13K.
Olema Oncology to Participate in Upcoming Investor Conferences in June
SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema", "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and